HIV and AIDS Trial, Recruiting NCT05652088 Sponsor: Icahn School of Medicine at Mount Sinai Condition: HIV and AIDS
Back to Hiv Aids

HIV and AIDS Trial, Recruiting

NCT05652088
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who are willing and able to sign and date a consent form agreeing to take part
  • People who are willing to follow all study procedures and lifestyle requirements, and who are available for the full duration of the study
  • Males and females between 18 and 75 years of age
  • People with a confirmed, long-term HIV-1 infection, verified through standard HIV testing methods
  • People who are currently receiving a treatment that has the potential to contribute to an HIV cure
  • People who are willing and able to undergo a colonoscopy procedure twice during the study period

Who may not be able to join:

  • People with a known blood clotting disorder or abnormal results on clotting tests
  • People who are pregnant or who plan to become pregnant during the study period
  • People who have an existing bowel condition such as Inflammatory Bowel Disease, ongoing diarrhoeal illness, or any other gut condition that could affect the lining of the intestine
  • People who currently have a sexually transmitted infection
  • People who have any other condition that the study doctors believe could affect their ability to safely participate in or complete the study (confirm with trial site)

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 6 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Francesca Cossarini, MD, Icahn School of Medicine at Mount Sinai

Phone: 212-659-9269

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Registry
ClinicalTrials.gov
Start date
30 June 2023
Est. completion
1 June 2026

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Change in HIV tissue viral load

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov